Avid Bioservices, Inc. is a full-service, dedicated contract development and manufacturing organization (CDMO) focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid’s services include process development and current good manufacturing practice (CGMP) clinical and commercial drug-substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support. For early stage programs, the company provides process development activities such as upstream and downstream development and optimization, pilot-scale manufacturing, analytical methods development, and testing and characterization. Avid has 28 years of experience producing a comprehensive range of proteins, including monoclonal antibodies (MAbs), recombinant proteins, bispecific monoclonal antibodies (bsAbs), Fc-fusion proteins, and biosimilars. The scope of our CDMO services ranges from stand-alone process development projects to full development and manufacturing programs through to commercialization.

Fill out the form below to read the complete capabilities review and learn more about Avid’s CDMO services now.